Feasibility of Biomedical Applications for Biomaterials in Bolivia

Abstract

Whether or not it is feasible for locally grown biomaterials to be translated into effective medical treatments in the Bolivian healthcare environment requires an assessment of cost, manufacturing capabilities, distribution, shelf life, etc. Of the biomaterials examined, sunflower seed oil seems to show the greatest promise due to its low cost and ease of use (Darmstadt et al. in Pediatr Infect Dis J 23(8):719–725, 2004). Other biomaterials requiring structural changes in development and manufacturing practices may face challenges in their assimilation. When introducing new medical technologies into the Bolivian landscape, it is vital to acknowledge and carefully work with the cultural norms and traditions of the region. For many Bolivians, traditional herbs and remedies may be regarded as just as valuable as, or more than, pharmaceuticals (Centellas in Sun god pharma: Bolivian pharmaceuticals and symbolic power, 2011). Concerns regarding good manufacturing practices in products manufactured locally (Bate in Local pharmaceutical production in developing countries. Campaign for fighting diseases, 2008), and tensions with American aid donors (Neuman in U.S. Agency is expelled from Bolivia. The New York Times, 2013) could be mitigated through Bolivian partnerships with other Latin American countries more established in the field of medical research and development.